The management of low-risk intraductal papillary mucinous neoplasms of the pancreas continues to represent an important clinical dilemma. Current guidelines lack of sufficient good-quality evidence, especially regarding the natural history of branch duct intraductal papillary mucinous neoplasms with no worrisome features. Herein, we aimed to summarize the current approach towards these lesions and the main controversial points regarding their management.
Maria Moris, Michael B Wallace
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : June 20, 2018